Browsing Tag
Luke Miels
4 posts
GSK stock jumps as insider Luke Miels named next CEO — can he deliver growth before HIV patent cliff hits?
GSK shares rise after naming Luke Miels as CEO-designate to succeed Emma Walmsley on Jan 1, 2026. Find out what investors expect next.
China’s shingles vaccine landscape revolutionized as GSK partners with Zhifei
Global pharmaceutical titan GSK plc is teaming up with Chongqing Zhifei Biological Products, Ltd. (Zhifei) – China’s leading…
GSK to acquire Canadian biopharma company BELLUS Health for $2bn
GSK has agreed to acquire BELLUS Health, a Canadian biopharma company, in a deal worth around $2 billion…
GSK to acquire US biopharma company Sierra Oncology for $1.9bn
GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9…